Advertisement
UK markets closed

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     

  • AIM

    745.67
    +0.38 (+0.05%)
     

  • GBP/EUR

    1.1613
    -0.0071 (-0.60%)
     

  • GBP/USD

    1.2371
    -0.0067 (-0.54%)
     

  • Bitcoin GBP

    51,842.66
    +638.95 (+1.25%)
     

  • CMC Crypto 200

    1,384.14
    +71.52 (+5.45%)
     

  • S&P 500

    4,955.64
    -55.48 (-1.11%)
     

  • DOW

    37,930.98
    +155.60 (+0.41%)
     

  • CRUDE OIL

    83.27
    +0.54 (+0.65%)
     

  • GOLD FUTURES

    2,407.10
    +9.10 (+0.38%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Olink Proteomics AB
·1-min read

UPPSALA, Sweden, May 25, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it will be participating in the Goldman Sachs 42nd Annual Global Healthcare Conference.

Jon Heimer, CEO and Oskar Hjelm, CFO are scheduled to participate in a virtual fireside chat on Wednesday, June 9th, 2021 at 8:50 a.m. ET.

A live and archived webcast will be available on the “Investors” section of the Olink website at investors.olink.com/investor-relations.

About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.


Contacts
Media and Investor Relations
Olink Holding AB (publ), Stina Thorman, stina.thorman@olink.com, +46707187354